Grants and Contributions:

Title:
EUREKA Network Project E!12216 / NDI: Rapid Omega-3 Fatty Acid Diagnostic Test
Agreement Number:
908598
Agreement Value:
$465,000.00
Agreement Date:
Jun 1, 2018 - Feb 28, 2021
Description:
The purpose of this project, EUREKA Network Project E!12216, is to develop the world’s first rapid, point-of-care omega-3 diagnostic device. This device will quickly tell users whether they have sufficient levels of the omega-3 fatty acid docosahexaenoic acid (DHA) in their blood. Project to be executed by Canada based Nutrasource Diagnostics Inc. and their Austria based partner SAICO Biosystems.
Organization:
National Research Council Canada
Expected Results:

Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.

Location:
Guelph, Ontario, CA N1G 0B4
Reference Number:
172-2018-2019-Q1-908598
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
865125264
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 272 days.

Amendment Date
May 15, 2020
Recipient's Operating Name:
NDI
Recipient's Legal Name:
Nutrasource Pharmaceutical and Nutraceutical Services Inc.
Federal Riding Name:
Guelph
Federal Riding Number:
35032
Program:
Eureka/Eurostar
Program Purpose:

Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.

Coverage:
EUREKA is a leading facilitator of innovation, providing a proven platform for international R&D&I cooperation.
NAICS Code:
541710
Amendments: